uridine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andren, A; Apiz-Saab, JJ; Brown, K; Carpenter, ES; Dzierozynski, LN; Halbrook, CJ; He, X; Kasperek, S; Lee, HJ; Lyssiotis, CA; Menjivar, RE; Muir, A; Nwosu, ZC; Nyamundanda, G; Pasca di Magliano, M; Patti, GJ; Poudel, P; Ps, H; Radyk, M; Ragulan, C; Sadanandam, A; Sajjakulnukit, P; Shi, J; Shriver, LP; Sutton, D; Tolstyka, Z; Ugras, J; Ward, MH; Zhang, L | 1 |
1 other study(ies) available for uridine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Uridine-derived ribose fuels glucose-restricted pancreatic cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Division; Cell Line, Tumor; Glucose; Humans; MAP Kinase Signaling System; Mice; Pancreatic Neoplasms; Ribose; Tumor Microenvironment; Uridine; Uridine Phosphorylase | 2023 |